News Feed Opinion Blog Posts Career Updates Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
August, 2025
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
Registrations are now open for ESTRO25
ESTRO/LinkedIn
Oct 30, 2024, 20:37

Registrations are now open for ESTRO25

ESTRO posted on LinkedIn:

“Registrations are now open for ESTRO25!
Benefit from the early registration deadline: 22 January 2025
Join us and be part of this transformative event in radiotherapy and oncology in Vienna next year!

Register now.
Explore the programme overview.
More info.”

cancer ESTRO ESTRO25 OncoDaily Oncology
Special Coverage
Voices
Aug 14, 2025, 06:12
Polikalipo Kagina: ORCI’s 30-Year Milestone
Societies
Aug 14, 2025, 06:03
How to Improve Survivorship Care Strategies in Head and Neck Cancer - EORTC
Voices
Aug 14, 2025, 05:42
Carolina Reduzzi: Exploring MRD Detection in Solid Tumors With Natera Test with Samuel Vilchez
Voices
Aug 14, 2025, 05:27
Support for Nyan, Hope for All Children - World Child Cancer USA
Dialogues
Aug 14, 2025, 03:06
Global Health Dialogues with Princess Dina Mired: HE Said Darwazah
Dialogues
Aug 14, 2025, 03:06
How Pfizer's BRAF-TOVI Breakthrough Is Revolutionizing MCC Treatment | Dr. Susan Zhang
Dialogues
Aug 14, 2025, 03:04
Empowering Oncologists: How coaching can make a difference?
Dialogues
Aug 14, 2025, 03:04
How Are LMICs Expanding Childhood Cancer Care with Limited Resources? | Second Global Oncothon
Opinion
Aug 14, 2025, 03:03
ONCOFFEE: Aviv Philip Goncharov – Navigating Residency and Research in Oncology Across Borders
Dialogues
Aug 14, 2025, 03:01
What’s Missing in Childhood Cancer Care? Global Experts Share Unfiltered Insights
Dialogues
Aug 14, 2025, 02:59
Why Cardio-Oncology Training Matters for Oncologists Treating Patients at Risk | MASCC 2025
New Paper Alert
Aug 14, 2025, 00:38
Survival Benefit of High TMB and BRAF Mutation in Advanced Melanoma on Adjuvant Anti–PD-1